Case Report: Molecular Diagnosis of Cystoisospora belli in a Severely Immunocompromised Patient with HIV and Kaposi Sarcoma.
Anti-Infective Agents
/ therapeutic use
Diarrhea
/ diagnosis
Eosinophilia
/ diagnosis
Female
Gastrointestinal Hemorrhage
/ diagnosis
HIV Infections
/ diagnosis
Humans
Immunocompromised Host
Isospora
/ immunology
Isosporiasis
/ diagnosis
Middle Aged
Sarcoma, Kaposi
/ diagnosis
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination
/ therapeutic use
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
29 11 2021
29 11 2021
Historique:
received:
09
03
2021
accepted:
06
10
2021
pubmed:
30
11
2021
medline:
3
3
2022
entrez:
29
11
2021
Statut:
epublish
Résumé
Diarrhea in an immunocompromised patient has a broad infectious differential. Diagnosis is difficult despite advances in diagnostic modalities. We report a case of a 45-year-old Nigerian woman who immigrated to the United States 2 years ago. She presented to the hospital with gastrointestinal bleeding, newly diagnosed HIV, and disseminated Kaposi sarcoma. During hospitalization, the patient had an onset of watery diarrhea and high eosinophilia. Subsequent stool analysis using multi-parallel real-time quantitative polymerase chain reaction for 13 parasites was positive for Cystoisospora belli. The patient was treated with trimethoprim-sulfamethoxazole, but had relapsed disease when her antibiotics were stopped prematurely. After restarting trimethoprim-sulfamethoxazole, her diarrhea and eosinophilia improved, and she had undetectable Cystoisospora belli DNA on repeat stool quantitative polymerase chain reaction. This case highlights the importance of a thorough workup for diarrhea, including parasites, especially for immunocompromised patients. Antibiotic prophylaxis is recommended in patients with Cystoisospora belli and HIV/AIDS.
Identifiants
pubmed: 34844211
doi: 10.4269/ajtmh.21-0289
pii: tpmd210289
pmc: PMC8832916
doi:
pii:
Substances chimiques
Anti-Infective Agents
0
Trimethoprim, Sulfamethoxazole Drug Combination
8064-90-2
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
678-680Références
BMC Infect Dis. 2016 May 21;16:221
pubmed: 27209066
Malays J Med Sci. 2009 Jul;16(3):41-4
pubmed: 22589664
Gastroenterology. 1974 May;66(5):923-35
pubmed: 4826994
Parasitol Int. 2018 Feb;67(1):1-3
pubmed: 28988952
J Emerg Med. 2011 Dec;41(6):e129-32
pubmed: 18993015
Ann Glob Health. 2019 Jul 05;85(1):
pubmed: 31276332
Am J Trop Med Hyg. 2013 Jun;88(6):1041-7
pubmed: 23509117
Curr HIV/AIDS Rep. 2015 Sep;12(3):313-6
pubmed: 26126686
Rev Peru Med Exp Salud Publica. 2013 Apr;30(2):326-30
pubmed: 23949523
Diagn Microbiol Infect Dis. 2011 Dec;71(4):386-90
pubmed: 21982218
Prim Care. 2016 Dec;43(4):607-617
pubmed: 27866580
Clin Colon Rectal Surg. 2015 Jun;28(2):79-86
pubmed: 26034403
J Infect Chemother. 2021 Feb;27(2):348-349
pubmed: 33132044
Curr Opin Infect Dis. 2013 Oct;26(5):479-83
pubmed: 23982239
Am J Trop Med Hyg. 1984 Nov;33(6):1060-4
pubmed: 6507724
Parasitology. 2019 Oct;146(12):1490-1527
pubmed: 31303182